A new kind of cancer gene therapy can be remotely activated at a specific part of the body. The team developed a version of ...

The biotech will cut 180 positions, or about two-thirds of its workforce, and discontinue development of its lead drug ...

When hiring job candidates to work on cell and gene therapies, companies look for more than just technical skills. Talent ...

CRISPR-Cas tools allow researchers to modify individual building blocks of genetic material in a precise and targeted manner.

CRISPR gene therapy trial for sickle cell disease begins, offering hope for a potential cure by targeting the genetic root of ...

Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...

An innovative CRISPR-Cas12f-based activator system may hold significant potential in the future of gene therapy and biological research, suggest researchers of a new study. Beremagene geperpavec ...

New genetic medicines for sickle cell disease were hailed as a milestone. Now researchers are working on ways to widen access ...

Two Saudi Arabian agencies signed on with Vertex Pharmaceuticals to help boost the countr | The Vertex agreement is part of ...

Preliminary data demonstrate that CTX112™ has the potential to provide meaningful clinical benefit with a well-tolerated ...

Vertex Pharmaceuticals Inc. and bluebird bio Inc. — are the first to take part in a new Medicaid model intended to expand ...

The payment scheme will tie gene therapy payments to improvements in health outcomes—and could potentially boost the uptake ...